Table 2.
Average routine childhood immunization visits during pre-COVID-19 lockdown period (November, 2019–March, 2020), lockdown period (April–-August, 2020), postlockdown period (September, 2020–January, 2021)
| Vaccine type | Before lockdown (5 months) n (mean) | During lockdown (5 months) n (mean) | After lockdown (5 months) n (mean) | Percent change during lockdown % | Percent change after lockdown % |
|---|---|---|---|---|---|
| Measles Ia | 685 (137) | 406 (81) | 563 (112) | −40.7 | −17.8 |
| Measles IIa | 557 (111) | 286 (57) | 444 (88) | −48.6 | −20.2 |
| Rota I | 642 (128) | 441 (88) | 542 (108) | −31.3 | −15.6 |
| Rota II | 598 (119) | 391 (78) | 540 (108) | −34.6 | −9.6 |
| Pentavalent I | 656 (131) | 434 (86) | 565 (113) | −33.8 | −13.8 |
| Pentavalent II | 609 (121) | 390 (78) | 545 (109) | −35.9 | −10.5 |
| Pentavalent IIIa | 568 (113) | 356 (71) | 538 (107) | −37.3 | −5.2 |
| Polio+PCV-10 I | 640 (128) | 443 (88) | 561 (112) | −30.7 | −12.3 |
| Polio+PCV-10 II | 601 (120) | 399 (79) | 543 (108) | −33.6 | −9.6 |
| Polio+PCV-10 III | 562 (112) | 365 (73) | 546 (109) | −35.0 | −2.8 |
PCV-10: Pneumococcal 10-valent conjugate vaccine.
a: I: mean first dose; II: second dose; III: Third dose.